An observational study in Stroke, Aging and Neuro-Degenerative Disease, sponsored by Karolinska Institutet. Recruiting at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-03.
Sponsored by Karolinska Institutet · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 27 studies in Stroke by Karolinska Institutet — 3 open to participants now, 5 under way, none of them phase 3. Stroke · Karolinska Institutet.
Among the 27 studies in Stroke by Karolinska Institutet, this one is the 9th largest by planned enrollment of the 11 observational ones that give a count, is one of 2 that started in 2026, is one of 11 observational ones, and was the 26th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →3 of the 27 studies in Stroke by Karolinska Institutet are open now, in 3 countries. Recruiting first, the newest first:
Karolinska Institutet · Sites in Finland, Sweden
Ages 18+
Karolinska Institutet · Sites in Uganda
Ages 13+
By country, each count listing its studies:
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
27 studies; the count open now beside each. This study's row is marked.
First in 1982; this study’s year is marked. 2 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 50 is below the median of 150 across 1,971 observational studies indexed under Stroke.
Median enrollment 113 across the 16 interventional studies, 179 across the 11 observational. Of the 21 that completed or were terminated, 1 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
Karolinska Institutet is the lead sponsor of 1,150 studies on the registry; 276 are open to participants now.
1 of the studies in Stroke by Karolinska Institutet that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07624630Karolinska InstitutetWalking and Thinking - Brain Activity During Complex Walking in Stroke | 2027-07-01 |
Add it to your calendar (.ics) → With an account.
Among the 27 studies in Stroke by Karolinska Institutet, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Everyday life requires individuals to function in complex environments and perform tasks that involve the integration of motor and cognitive abilities. However, stroke often leads to impairments in motor-cognitive interaction, which can negatively affect mobility, balance, attention, and the ability to live independently. Although motor-cognitive performance has been identified as an important rehabilitation target after stroke, limited knowledge exists regarding the underlying brain function associated with these difficulties and how rehabilitation and exercise interventions can best address them.
Improving treatment for motor-cognitive difficulties after stroke, such as dual-task walking and navigation, remains a major challenge. An important step is developing assessment methods that accurately capture these impairments in ecologically valid settings that reflect real-world mobility demands. The investigators therefore aim to explore brain function during complex walking after stroke by investigating motor-cognitive performance and its neural correlates during three walking conditions: dual-task walking, navigation, and a combination of both. Non-invasive measures of brain activity using functional near-infrared spectroscopy (fNIRS) together with advanced real-time gait analysis will be used to better understand how stroke affects motor-cognitive functioning during complex walking tasks.
BACKGROUND Stroke is one of the leading causes of mortality and disability in the world and the prevalence of stroke-related disability is expected to increase globally. In Sweden, about 29,000 individuals are affected by stroke every year. Individuals who have suffered a stroke often experience a high incidence of motor and cognitive impairment which are associated with insufficient blood supply and brain oxygenation. One main objective in post-stroke rehabilitation is fostering the capability to walk and navigate the community safely, aiming to uphold independence, facilitate social integration, and encourage active participation in society. Challenges such as impaired balance and compromised turning abilities are often manifested through irregularities in gait and an elevated risk of falls in individual's post-stroke. These difficulties may potentially result in injuries, restrictions in daily activities, and limitations in social engagement for people post stroke.
Complex walking and dual tasking. The achievement of safe and efficient walking relies on a delicate balance between automaticity, involving movements that require minimal attention, and executive control processes, which involve movements requiring attention. The automatic control of walking is essential for ensuring safe ambulation, allowing executive control to be directed towards other crucial aspects of the environment (e.g., navigating in crowded areas) or concurrent tasks (e.g., walking and talking on the phone). Assessment of walking automaticity commonly involves dual-tasking, where two tasks with distinct goals are performed simultaneously, such as walking while engaging in a cognitive task.
Increasing evidence indicates a strong correlation between mobility, and cognitive processes, with people post stroke documented to show the highest level of cognitive-motor interference (i.e., the relative cost of dual-tasking) when performing concurrent working memory and balance tasks. Therefore, developing and establishing robust methods to concurrently assess cortical activity and complex walking hold significant potential to provide insight into cognitive processes driving mobility in people post stroke.
Measurement of cortical activity during complex walking. While functional magnetic resonance imaging (fMRI) is considered the gold standard for functional neuroimaging, its applicability is constrained when studying gait and balance is limited. Functional near-infrared spectroscopy (fNIRS) is a novel and non-invasive imaging method that utilizes the optical properties of neuronal activity to measure changes in the concentration of oxygenated and deoxygenated hemoglobin in cortical regions. This new technology combined with the measurement of behavior (i.e., gait parameters) has the potential to measure real-time cortical activity during ecologically valid states at low costs. This is of importance for health science who often aim to study individuals' capacities to be active and participate in everyday life activities.
This study builds on previous work done by our research team, who developed and tested the feasibility of using fNIRS to measure cortical activity during different complex walking conditions in healthy adults. Promising results were found in the pilot study, and the research team further developed the protocol to include people with Parkinson's and multiple sclerosis. To date few studies have used fNIRS to investigate complex walking in people post stroke and these studies have several limitations which include homogenous and small cohorts.
The investigators are in a strong position to carry out this truly innovative research. The findings of this project will enrich the knowledge of cognitive processes driving mobility and dual tasking in people post stroke, which in turn, could facilitate the development of effective strategies and novel interventions.
PURPOSE AND GOALS The overarching purpose of this project is to clinically assess motor cognitive performance during complex walking and dual-tasking conditions by integrating a non-invasive measure of brain activity i.e. fNIRS and objective assessments of motor behavior in people post stroke. The goals of this project are to 1) validate complex walking protocols developed previously for people with neurological diseases for evaluating motor-cognitive performance and assessing brain activity using fNIRS in individual's post-stroke. 2) investigate differences in cortical activity with walking performance during complex walking tasks and compare it to healthy adults, people with Parkinson's disease and multiple sclerosis; 3) establish correlations between fNIRS-derived cortical activity and walking performance metrics (i.e., gait speed and stride length) to gain insight into the relationship between brain activity, cognitive performance, disease severity and functional outcomes in people post stroke.
MATERIALS AND METHODS Study Participants: A sample of 50 participants post stroke will be recruited through patient organizations, advertisements and established collaborating clinical sites in Stockholm (e.g., Karolinska University Hospital and Stora Sköndal).
Inclusion criteria: Individuals with a stroke ≥ 6 months confirmed by a clinical diagnosis according to established criteria before study enrollment and being able to ambulate continuously indoors with/without a walking aid for ≥5 minutes. Exclusion criteria: Individuals post stroke with cognitive impairment, severe neglect, and global aphasia affecting the ability to provide written informed consent, severe perceptual problems (e.g., spatial neglect) or severe freezing of gait.
Data collection: Prior to data collection, individuals meeting the inclusion criteria will receive written and oral information about the study. All included study participants will attend 2 sessions at the uMOVE core facility, Karolinska University Hospital, Stockholm. The assessment detailed below consists of interviews, clinical tests, gait measures, and cortical activity measurements using fNIRS and will be conducted a week apart.
Session 1 comprises:
Cortical brain activity - Changes in oxygenated (HbO) and deoxygenated (HHb) hemoglobin in the prefrontal cortex will be measured using the NIRSPORT 2 (NIRx Medizintechnik, Berlin, Germany) continuous wave fNIRS device. During each protocol, the participants will be fitted with an fNIRS cap with 16 sources and 16 detectors, and a controller box attached to a backpack harness. The source optodes transmit infrared light at 760 and 850 nm and the detector optodes record changes in HbO and HHb at 10 Hz. Optode placement will be arranged according to the international 10-20 system over the prefrontal area.The fNIRS data will be streamed wirelessly to a local computer using the Aurora software.
Measurement of gait and behavioral parameters - Simultaneously gait parameters (e.g., walking speed and cadence) will be measured using 3 inertial measurement units (OPAL APDM inc.) positioned at on top of each foot and around the lumbar. The sensors will continuously stream data to a local computer using the Mobility LabTM software. To measure mistakes during navigational walking the investigators will mount a GoPro camera on the chest of each participant pointing to the feet. Additionally, the auditory Stroop verbal responses will be recorded through headphones using the Audacity software (version 2.4.2).
Session 2 comprises questionnaires and clinical assessments:
We are studying complex walking in four different populations, people with stroke, healthy adults, people with Parkinson's disease and people with Multiple Sclerosis. We have during 2022-2025 completed data collection (ClinicalTrials.gov ID: NCT06906276, NCT05218213 and NCT05787704) of healthy adults, people with Parkinson's disease and people with Multiple Sclerosis. Hence, this registration concerns the stroke cohort
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: No Interventions
This study includes assessment of brain activity with functional Near Infrared Spectrscopy (fNIRS) and behavioural assessments (motor, motor-cognitive and cognitive) during three complex walking conditions. Dual-task walking with the auditory stroop task. Navigational walking - a course consisting of a distribution of 45 and 90 degrees turns to the left and right Navigational and dual-task walking (condition 1 and 2 together)
Functional near infrared spectrometry (fNIRS)
The measurement of changes in concentration of oxygenated hemoglobin (HbO) and deoxygenated hemoglobin (HHb) in the prefrontal cortex will be assessed using a NIRSPORT 2 (NIRx Medizintechnik, Berlin, Germany) device.
Time frame: Baseline
Stride time during all conditions
Stride time will be analyzed with the APDM mobility system.
Time frame: Baseline
Velocity during all conditions
Velocity will be analyzed with the APDM mobility system.
Time frame: Baseline
Dual-task performance-reaction time
Cognitive performance of the dual task will be assessed as errors in the response to the Auditory stroop task.
Time frame: Baseline
Cognitive performance
Global cognitive performance will be assessed with the Montreal Cognitive Assessment (MoCA). Scores range from 0-30, with higher score indicating better performance.
Time frame: Baseline
Stroke severity
Assessed using the National Institutes of Health Stroke Scale (NIHSS). Scores range from 0-42, with higher scores indicating greater stroke severity.
Time frame: Baseline
Stroke specific health status
Assessed using the Stroke Impact Scale (SIS). Scores range from 0-100, with higher scores indicating better functioning
Time frame: Baseline
Physical Impairment
Assessed using the Chedoke McMaster Stroke Assessment. Scores range from 1-7 for each impairment dimension, with higher scores indicating better motor recovery.
Time frame: Baseline
Walking ability
Assessed using the Walk-12G. Scores range from 0-42, with higher scores indicating greater walking difficulties
Time frame: Baseline
Balance performance
Assessed with the Mini-BESTest (Balance Evaluation Systems test). Scores range from 0-28, with higher scores indicating better balance performance.
Time frame: Baseline
Anxiety and Deprssion
Assessed with Hospital Anxiety and Depression Scale (HADS). Scores range from 0-24 for the anxiety and depression subscales, respectively, with lower scores indicating fewer symptoms of anxiety and depression
Time frame: Baseline
Cognitive function - Attention and psychomotor processing speed
Attention and psychomotor processing speed will be assessed with the Trail Making Test (TMT) from D-KEFS (Delis-Kaplan Executive Function System).
Time frame: Baseline
Cognitive function - Episodic memory
Episodic memory will be assessed with the Ray Auditory Verbal Learning Test (RAVLT).
Time frame: Baseline
Self-reported level of physical activity
Assessed with the Frändin-Grimby Scale. Scores range from 1-6, with higher scores indicating higher levels of physical activity.
Time frame: Baseline
Cognitive function - verbal fluency
Verbal function, initiation \& task-set switching with the Verbal Fluency test from D-KEFS (Delis-Kaplan Executive Function System).
Time frame: Baseline
Physical activity levels
Assessed with acceleromters (Actigraph GT3X+)
Time frame: Baseline
Dual-task performance -errors
Cognitive performance of the dual task will be assessed as the reaction time to respond during Auditory stroop
Time frame: Baseline
Navigation errors
Assessed using a GoPro camera
Time frame: Baseline
Plan to share: Yes — The datasets generated during and/or analysed during the current study are not publicly available due to Swedish and EU personal data legislation but are available from the principal investigator on reasonable request. Any sharing of data will be regulated via a data transfer and user agreement with the recipient.
Supporting information: Statistical analysis plan, Analytic code
Time frame: We plan to share this when applicable on OSF or similar
Access criteria: The datasets generated during and/or analysed during the current study are not publicly available due to Swedish and EU personal data legislation but are available from the principal investigator on reasonable request. Any sharing of data will be regulated via a data transfer and user agreement with the recipient.
No publications or documents are linked to this record.
Start is estimated for Aug 2026; primary completion for Jul 2027, 11 months later.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.